SecBot SecBot

TDACW

Translational Development Acquisition Corp.
Nasdaq· Blank Checks· CIK 0001926599 Traditional Finance
Warrants of Translational Development Acquisition Corp. · TDAC stock page →
—
1 year
+4.2%
from $10.40 · Oct 28
30 days
−0.1%
from $10.85
52-week range
$10.40–10.90
−1% from high · low Oct 28
Avg volume 20D
7.9K
Oct 13 spike 35.9K
Short interest
102
−62.5%
Days to cover
1.0
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
3
analyzed by SecBot
SecBot read BULLISH 3 reports · latest
Balance 0 bearish · 2 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 3/3
Strongest BULLISH Translational Development Acquisition Corp. (TDAC) has filed the definitive merger agreement and supporting…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 2 added (0 new), 2 trimmed or exited.

  • Short sellersCOVERING

    Short interest −62.5% to 102 shares. 1.0 days to cover.

  • TrendDOWNTREND

    0% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
LINDEN ADVISORS LPDOUBLED1,317,931$1.9M
LMR Partners LLPADD755,000$1.1M
Verition Fund Management LLCTRIM191,700$253.0K
Clear Street Group Inc.TRIM89,393$127.4K

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
102
shares short
-62.5%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 30, 2026 Inst.
LINDEN ADVISORS LP — DOUBLED
1,317,931 shares ($1.9M)
Jun 30, 2026 Inst.
LMR Partners LLP — ADD
755,000 shares ($1.1M)
May 27, 2026 SEC
Translational Development Acquisition Corp. (TDAC) has filed the definitive merger agreement and supporting documents…
425 — Impact 7/10
May 27, 2026 SEC
Translational Development Acquisition Corp. (TDAC) has entered into a definitive merger agreement to acquire Prologium…
8-K — Impact 7/10
May 6, 2026 SEC
Translational Development Acquisition Corp. filed Amendment No.1 to its 10-K for FY2025 solely to revise Part II, Item…
10-K/A — Impact 2/10

SecBot reports

3 filings · 2 bullish · 0 bearish · 1 neutral
All TDACW filing & press-release reports (3)